Drug intelligence / Profile preview

ViviGen (LifeNet Health)

Development stage
Unknown
Lead developer
LifeNet Health
Modality
Stem Cell Therapies → Cell Therapies
Administration
Implant
01

Overview

ViviGen is a cellular bone matrix (cellular allograft) developed by LifeNet Health and distributed by DePuy Synthes. It is designed to provide a comprehensive solution for bone repair by delivering the three essential components of bone formation: osteoconduction, osteoinduction, and osteogenicity. Unlike traditional allografts, ViviGen contains cryopreserved, viable, lineage-committed bone cells (osteoblasts, osteocytes, and bone lining cells) within a corticocancellous bone scaffold and demineralized bone matrix. This composition allows it to mimic the properties of an autograft, which is considered the gold standard in bone grafting. It is primarily indicated for use in orthopedic and spine fusion procedures, such as lumbar and cervical fusion, as well as for the treatment of non-union fractures and traumatic bone defects.

Brand names
ViviGenViviGen Cellular Bone Matrix
Other names
ViviGen Cellular Bone Matrix

Beyond the preview

Go deeper on ViviGen (LifeNet Health).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ViviGen (LifeNet Health).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call